Description: Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
Home Page: www.medipal.co.jp
3-1-1 Kyobashi
Tokyo,
104-8461
Japan
Phone:
81 3 3517 5800
Officers
| Name | Title |
|---|---|
| Mr. Shuichi Watanabe | Chief Compliance Officer, CEO, President & Representative Director |
| Mr. Yuji Sakon | MD, GM of Administration Division & Director |
| Mr. Toshihide Yoda | Senior MD of Investor Relations, GM of Business Development Department & Director |
| Mr. Yasuhiro Choufuku | Executive VP & Director |
| Mr. Shinjiro Watanabe | GM of Information Systems Management Division & Director |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Distributors |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 10.4252 |
| Price-to-Book MRQ: | 0.6735 |
| Price-to-Sales TTM: | 0.001 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 13075 |